Clinical trial Recruiting at 1 site Observational Ages 18 and up

Impact of Sleeve Gastrectomy on Bone and Muscle Health in Men and Women

Official title: Bone and Muscle Health Following Sleeve Gastrectomy in Men, Premenopausal and Postmenopausal Women

Run by CHU de Quebec-Universite Laval · NCT06547515 · Data updated 2026-11-12

This study is trying to see how sleeve gastrectomy affects bone and muscle health in men and women over three years.

More Bariatric Surgery trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment156 (estimated)
SponsorCHU de Quebec-Universite Laval
Academic / other
Locations1 site (Québec)
StatusRecruiting
StartedSeptember 14, 2022
Main results expectedAugust 15, 2026
Study endsAugust 15, 2026
Registry record updatedJune 10, 2025
Trial IDNCT06547515 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include men and women over 18 years old who are either awaiting sleeve gastrectomy or meet the criteria for surgery but are not undergoing the procedure.

Probably not a fit

Patients with type 1 diabetes, uncontrolled thyroid disease, or other metabolic bone diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the effects of sleeve gastrectomy (SG) on bone and muscle health in men and women, including premenopausal and postmenopausal women. It will compare changes in spine volumetric bone mineral density (vBMD) and muscle mass at the mid-femur between individuals who undergo SG and those who do not. Participants will be followed for three years, with assessments conducted using quantitative computed tomography (QCT) and computed tomography (CT). The study seeks to understand the potential risks associated with SG, particularly regarding bone and muscle loss.

Why it matters

Potential benefit: If successful, this study could provide insights into the long-term effects of sleeve gastrectomy on bone and muscle health, potentially guiding better post-operative care for patients.

How similar studies have gone: While there is existing research on the effects of bariatric surgery on bone health, this specific focus on sleeve gastrectomy and its comparative analysis with non-surgical peers is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men and women aged \>18 years;
* Awaiting SG for the bariatric group or meeting the criteria for SG but not undergoing surgery for the non-surgical group.
* Menopause: defined as the absence of menses for a year and a serum follicular-stimulating hormone (FSH) \>40 UI/L.
* Women taking oral contraceptive pills or hormone replacement therapy
* Patients with type 2 diabetes.

Exclusion Criteria:

* Type 1 diabetes;
* Disease (e.g., uncontrolled thyroid disease, Malabsorptive or overt inflammatory disorder)
* Metabolic bone disease other than osteoporosis or type 2 diabetes,
* Creatinine clearance \<30 ml/min) or medication (e.g., glucocorticoids, anti-epileptic drugs, osteoporosis therapy, thiazolidinediones) affecting bone metabolism;
* Weight \>204 kg (DXA weight limit) or BMI \>60 kg/m2 (upper limit to allow for QCT examination);
* Current or planned pregnancy during follow-up; breast-feeding.

Where it's running

  • Centre de recherche de l'IUCPQ
    Québec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.